Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mack, G. Osiris seals billion-dollar deal with Genzyme for cell therapy. Nat Biotechnol 27, 106–107 (2009). https://doi.org/10.1038/nbt0209-106
Issue Date:
DOI: https://doi.org/10.1038/nbt0209-106
- Springer Nature America, Inc.
This article is cited by
-
Challenges in the translation and commercialization of cell therapies
BMC Biotechnology (2015)
-
Genzyme backs Osiris, despite Prochymal flop
Nature Biotechnology (2009)